CMF is the abbreviation for a chemotherapeutic regimen (i.e., combination of the chemotherapeutic drugs) consisting of cyclophosphamide (C), methotrexate (M), and 5-fluorouracil (F).
Some women with breast cancer of Stage I and higher receive adjuvant (i.e., post-surgical) treatment with CMF.
|